SHULMAN STEPHEN 4
4 · GALECTIN THERAPEUTICS INC · Filed Jan 18, 2019
Insider Transaction Report
Form 4
SHULMAN STEPHEN
Director
Transactions
- Award
Stock option (right to buy)
2019-01-16+25,000→ 25,000 totalExercise: $4.72Exp: 2029-01-16→ Common stock (25,000 underlying)
Footnotes (1)
- [F1]The options vest 100% on January 16, 2020.